NEW CUTTING-EDGE ONCOLOGY TRAINING WITH CNAO: EXCELLENCE IN HADRONTHERAPY EDUCATION
The CNAO (National Center for Oncological Hadrontherapy) proudly offers three exceptional educational opportunities aimed at advancing the knowledge and expertise of healthcare professionals in the field of Hadrontherapy. With a strong commitment to excellence, CNAO provides world-class training designed to keep clinicians at the forefront of cancer treatment. These courses delve into the groundbreaking use of particle therapy—proton and carbon ion therapies—that is revolutionizing oncology.
Think Hadrom – Discovering Hadrontherapy in Multidisciplinarity: Focus on Paediatric Radiation Oncology
This prestigious course explores the highly specialized use of radiation therapy in treating pediatric cancers, an area where expertise and precision are crucial. Leading experts in pediatric radiation oncology share invaluable insights, focusing on the use of proton therapy—a cutting-edge treatment modality that is setting new standards in the care of young patients. Proton therapy is recognized for its unparalleled precision and effectiveness in treating solid tumors in children, and it is poised to make a transformative impact across Europe.
Target Audience: Specialists in pediatric oncology, radiation oncology, surgery, and other related fields, who are committed to providing the highest level of care to pediatric patients.
Course Content Includes:
- Retinoblastoma, Atypical Teratoid Rhabdoid Tumor, Craniopharyngioma, Medulloblastoma, and more.
- In-depth clinical outcomes and the effects of various radiation techniques.
Why Choose This Course?
This course offers unparalleled expertise, delivered by renowned leaders in pediatric oncology, and offers healthcare professionals a deep dive into the innovative, life-saving applications of proton therapy for children—a true game-changer in modern cancer care.
Think Hadrom – Discovering Hadrontherapy in Multidisciplinarity: Focus on the Therapeutic Management of Bone and Soft Tissue Sarcomas
As a center of excellence in Hadrontherapy, CNAO offers this advanced course that emphasizes the transformative role of particle therapy in the treatment of bone and soft tissue sarcomas. This training equips healthcare professionals with the most current and scientifically advanced methods for managing these complex cancers. With particle therapy’s ability to target tumors more precisely while minimizing damage to surrounding tissues, it stands as a premier alternative to conventional photon therapy.
Target Audience: Oncologists, surgeons, and radiotherapists specializing in sarcomas, along with other healthcare providers seeking to elevate their expertise in cutting-edge cancer therapies.
Course Content Includes:
- Innovations in surgery and radiotherapy for sarcomas.
- Proton and carbon ion therapies as groundbreaking treatments for sarcomas.
Why Choose This Course?
CNAO’s vast experience and expertise in Hadrontherapy ensure participants receive top-tier, clinically relevant training on the most promising therapies for treating bone and soft tissue sarcomas. This is an opportunity to learn from the best in the field and stay ahead of the curve in the fight against sarcoma.
Think Hadrom – Discovering Hadrontherapy in Multidisciplinarity: Focus on Gynecological Oncology
CNAO continues to lead the way in the use of advanced particle therapies for cancer treatment, offering this specialized course on gynecological oncology. With a focus on rare tumors and innovative treatments, this course provides an in-depth understanding of the clinical benefits of proton and carbon ion therapies for gynecological cancers. As one of the foremost institutions in Hadrontherapy, CNAO’s expertise in this area ensures that participants are learning from a world leader in the field.
Target Audience: Gynecological oncologists, radiotherapists, and other healthcare providers involved in the management of gynecological cancers, particularly rare and complex cases.
Course Content Includes:
- Carbon ion and proton therapies for gynecological cancers.
- Exploring new frontiers in radiotherapy for cervical, ovarian, and other gynecological cancers.
Why Choose This Course?
The integration of Hadrontherapy in the treatment of gynecological cancers represents a cutting-edge approach that is not only scientifically sound but also immensely promising in improving patient outcomes. With CNAO’s deep expertise and advanced technological capabilities, this course is an outstanding opportunity to gain knowledge that is at the frontier of cancer care.
How to Register:
- Visit the CNAO’s Accademia Nazionale di Medicina virtual classroom: https://fad.accmed.org
- Register for the course by completing the required information.
- Once registered, access the course materials and complete the learning path.
- After completing the course, pass the final test and evaluation to receive the ECM certification.
At CNAO, excellence is at the core of everything we do. These advanced FAD courses reflect our commitment to providing world-class education in Hadrontherapy and oncology. By participating in these courses, healthcare professionals will gain exclusive access to groundbreaking research, innovative treatments, and the latest advancements in the field—ensuring they are equipped with the knowledge and skills to deliver the best care for their patients. Don’t miss this opportunity to enhance your expertise with the leaders in Hadrontherapy.
References: CNAO News
Worldwide, only six facilities have the capacity to perform hadrontherapy treatments using protons and carbon ions. One of these is located in Pavia, just half an hour away from Milan: the CNAO, National Centre for Oncological Hadrontherapy, the only centre in Italy able to perform this task.
LEARN MORE
Hadrontherapy is a form of radiotherapy for the treatment and cure of tumours that are often surgically inoperable (located in particularly difficult locations) or resistant to traditional radiotherapy treatments (they do not respond sufficiently or adequately to the X-rays used in traditional radiotherapy). Since 2017, the Italian national healthcare service has incorporated this therapy into its basic service offerings.
Hadron therapy is based on the use of protons and carbon ions. Hadrons, atomic particles used in the therapy named after them, are more effective in destroying cancer cells than electrons due to their increased weight and energy.
To achieve precise tumour targeting, hadrons must undergo strong acceleration using a particle accelerator. At the National Centre for Oncological Hadron Therapy (CNAO) in Pavia, Italy, the treatment process occurs within the “synchrotron”, an 80-metre ring of medical equipment that links to the treatment rooms where patients receive care.
The synchrotron provided to the CNAO in Pavia is the sole unit in Italy that can extract carbon ions from the atom, which are the most potent particles, to treat tumours that resist conventional radiotherapy or are inoperable. There are only five other centres worldwide capable of achieving this.
Reference: For more information, please refer to the Hadrontherapy: Synchrotron webpage
The number of hadron therapy sessions necessary varies based on various factors, including the type of particle used, tumour type, size, and location. Typically, individuals require one session per day, five days a week, for 2 to 7 weeks.
The physical characteristics of carbon ions and protons utilized in hadron therapy provide several significant benefits over conventional radiotherapy.
The treatment of radioresistant tumours is possible with a high level of precision which helps in preserving healthy tissue.
The combination of these advantages results in a considerable destructive effect on the tumour tissue, making it a crucial requirement to position the tumour with millimetre accuracy, far more precise than conventional radiotherapy. The combination of these advantages results in a considerable destructive effect on the tumour tissue, making it a crucial requirement to position the tumour with millimetre accuracy, far more precise than conventional radiotherapy. Additionally, personalisation of the treatment at each phase further contributes to enhancing the treatment outcome. The combination of these advantages results in a considerable destructive effect on the tumour tissue, making it a crucial requirement to position the tumour with millimetre accuracy, far more precise than conventional radiotherapy.
Patients can determine if their cases or pathologies are treatable with hadron therapy by consulting the CNAO Foundation’s website. See
Upon verifying their eligibility, patients can learn about the preliminary assessment and subsequent steps required to begin treatment. Confirmation of eligibility will be granted after the first visit. See
